---
title: "Hezong Medicine Easy-To-Buy Pharmaceutical released its 2024 annual performance, with a net profit attributable to the parent company of 16.3582 million yuan, a decrease of 72.52%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/235427951.md"
description: "Hezong Medicine Easy-To-Buy Pharmaceutical released its 2024 annual report, with operating revenue of 4.381 billion yuan, a year-on-year decrease of 1.12%; net profit attributable to the parent company was 16.3582 million yuan, a year-on-year decline of 72.52%; net profit excluding non-recurring gains and losses was 12.3697 million yuan, a year-on-year decrease of 77.10%. The basic earnings per share were 0.17 yuan, and it plans to distribute a cash dividend of 1 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-04-10T12:18:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/235427951.md)
  - [en](https://longbridge.com/en/news/235427951.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/235427951.md)
generator: "portal-rs"
---

# Hezong Medicine Easy-To-Buy Pharmaceutical released its 2024 annual performance, with a net profit attributable to the parent company of 16.3582 million yuan, a decrease of 72.52%

According to the Zhitong Finance APP, Hezong Medicine Easy-To-Buy Pharmaceutical (300937.SZ) released its 2024 annual report, stating that the company's operating income was 4.381 billion yuan, a year-on-year decrease of 1.12%. The net profit attributable to shareholders of the listed company was 16.3582 million yuan, a year-on-year decrease of 72.52%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 12.3697 million yuan, a year-on-year decrease of 77.10%. The basic earnings per share were 0.17 yuan. In addition, it plans to distribute a cash dividend of 1 yuan (including tax) for every 10 shares to all shareholders

### Related Stocks

- [300937.CN](https://longbridge.com/en/quote/300937.CN.md)

## Related News & Research

- [PROXI: Operational improvements and refinancing set the stage for profitability as harvest sizes grow](https://longbridge.com/en/news/297267075.md)
- [Georgian Developer Origami Holding Launches $200M Mixed-Use Project on Batumi’s Ambassadori Island](https://longbridge.com/en/news/297327599.md)
- [Paramount Resources Ltd. (OTCMKTS:PRMRF) Receives Consensus Recommendation of "Moderate Buy" from Brokerages](https://longbridge.com/en/news/297146200.md)
- [Jinhui Shipping, Jinhui Holdings subsidiary, posts Q2 net profit of US$5.27 million](https://longbridge.com/en/news/297122309.md)
- [Slink Launches New Platform to Reinvent the IT Experience for Growing Businesses](https://longbridge.com/en/news/297329556.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**